What Does the Democratic Sweep Mean for US Cannabis?
Last week’s US midterm elections have transformed the political map of the country, handing both the House and the Senate over to the Democrats.
Last week’s US midterm elections have transformed the political map of the country, handing both the House and the Senate over to the Democrats.
As the US cannabis industry eagerly awaits the judge’s final recommendation on whether to extend rescheduling, the next phase has already found itself caught in the weeds of bureaucracy.
Thailand’s Ministry of Public Health is pressing ahead with a draft Cannabis and Hemp Act that would restrict its liberal cannabis market to purely medical and research use cases.
Earlier this month (July 10, 2026), the German government voted through a sweeping set of provisions set to significantly impact medical cannabis patients who have their prescriptions covered by their statutory health insurance.
Written by Omar Khan, Chief Communications and Public Affairs Officer, High Tide Inc.
Northern Leaf has partnered with Canadian biotech firm 3R Biotech to open 3R Europe, a facility combining cannabis plant testing, cleaning, preservation and reproduction at a single site for the first time in Europe.
Switzerland has granted approval for a new five-year, 5000-participant adult-use cannabis pilot trial, marking the eighth since the groundbreaking project began in 2023.
Ireland’s Oireachtas Joint Committee on Drugs Use has recommended the full decriminalisation of personal possession of all drugs, calling on the government to repeal Section 3 of the Misuse of Drugs Act 1977.
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have wasted no time in capitalising on the historic reclassification.